InforMax (inmx) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InforMax (inmx)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (14)	3/29/2002 9:16:50 AM
From: Jim Oravetz	Read Replies (1) of 18

Johns Hopkins’ Microarray Core Facility Licenses InforMax’s GenoMax By a GenomeWeb staff reporter NEW YORK, March 26 - InforMax said on Tuesday it has licensed its GenoMax informatics platform to Johns Hopkins University School of Medicine Microarray Core Facility. Financial terms of the agreement were not disclosed. Two weeks ago, InforMax named Andrew Whiteley president, chairman, and CEO. Whiteley takes over from Alex Titomirov, the company's founder, who is resigning from the company immediately, InforMax said in a statement. Whiteley, who came to InforMax from Amersham, said he plans immediately to bolster his company's marketing efforts.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next